Stocksigma LogoStocksigma Logo

Accretion Pharma Board Approves Key Proposals for Shareholder Vote

Accretion Pharmaceuticals' Board, on 1st Sep'26, approved key proposals subject to shareholder approval via postal ballot

Accretion Pharma Board Approves Key Proposals for Shareholder Vote

Accretion Pharmaceuticals Ltd 路 Others (Uncategorized) 路 01 Sept 2026, 7:15 pm

Accretion Pharma Board Approves Key Proposals for Shareholder Vote Accretion Pharmaceuticals' Board, on 1st Sep'26, approved key proposals subject to shareholder approval via postal ballot. These include altering the company's Object Clause in its Memorandum of Association to expand business activities. The Board also seeks to increase borrowing limits, enhance limits for creating security on company assets, and approve loans, guarantees, and investments exceeding prescribed thresholds under the Companies Act, 2013. These moves signal potential strategic expansion and future capital-raising activities, pending shareholder and regulatory consent.

Original exchange filing (PDF)

More announcements from Accretion Pharmaceuticals Ltd

All Accretion Pharmaceuticals Ltd announcements